<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01595412</url>
  </required_header>
  <id_info>
    <org_study_id>NTR2743</org_study_id>
    <nct_id>NCT01595412</nct_id>
  </id_info>
  <brief_title>An International Double Cohort Study to Compare Laparoscopic Ventral Rectopexy With Laparoscopic Resection Rectopexy</brief_title>
  <acronym>LaProS</acronym>
  <official_title>Laparoscopic Rectal Prolapse Surgery Study. An International, Double Cohort Study to Determine the Optimal Treatment for Rectal Prolapse.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Rectal prolapse (RP) is the descent of the upper rectum and is a common problem in the&#xD;
      western world. Surgery is the only definite treatment and is preferably performed minimally&#xD;
      invasive. High-level prospective studies on treatment strategies for RP currently are lacking&#xD;
      and, thus, no consensus exist regarding the optimal treatment for patients with RP.&#xD;
      Furthermore, remarkable transatlantic differences exist, as in Europe, laparoscopic ventral&#xD;
      rectopexy (LVR) is regarded the treatment of choice, while in the USA Laparoscopic Resection&#xD;
      Rectopexy (LRR) remains the golden standard.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      To determine the optimal minimally invasive surgical treatment for patients with RP.&#xD;
&#xD;
      Design:&#xD;
&#xD;
      International, prospective, comparative double cohort study. The first cohort will consist of&#xD;
      120 European patients with a RP and will be treated with LVR. Centres in The Netherlands,&#xD;
      Belgium and the UK are enlisted for participation. The second cohort will consist of 120&#xD;
      American patients with a RP, treated with LRR. Several US centres are enlisted. Preoperative&#xD;
      work-up consists of radiological imaging and standardised questionnaires. Follow-up (FU) is&#xD;
      set on two years. During FU, pre-operative imaging and questionnaires will be repeated.&#xD;
&#xD;
      Primary &amp; secondary outcomes:&#xD;
&#xD;
      Primary endpoint will be improvement on the Gastro-Intestinal-Quality-of-Life-Index (GIQLI).&#xD;
      Secondary endpoints will be generic Quality-of-Life, functional results, morbidity,&#xD;
      mortality, recurrences and cost-effectiveness.&#xD;
&#xD;
      Time frame:&#xD;
&#xD;
      Study and inclusion start will be on January the 1st, 2011 and will take approximately 18-24&#xD;
      months. Therefore, total study duration will be 42-48 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Rectal Prolapse (RP), or procidentia, is the descent of the upper rectum. This descensus in&#xD;
      the full-thickness of the rectum, and can be either internal, called an internal rectal&#xD;
      prolapse or intussusception (IRP), or through the anus (called an external rectal prolapse&#xD;
      (ERP)).&#xD;
&#xD;
      RP mainly occurs in women (80-90%) of which most in the 6-7th decade. Risk factors for&#xD;
      developing a rectal prolapse are the presence of an abnormal deep pouch of Douglas, laxity&#xD;
      and atonic condition of the muscles of the pelvic floor and anal canal. Moreover, weakness of&#xD;
      both internal and external sphincters, often with evidence of pudendal nerve neuropathy and&#xD;
      the lack of normal fixation of the rectum may lead to RP. This also frequently leads to other&#xD;
      pelvic organ prolapses like vesicoceles, enteroceles and genital prolapses. In this study the&#xD;
      investigators will focus on the treatment of RP.&#xD;
&#xD;
      Rectal prolapses cause anal incontinence in more than half of the patients. Another frequent&#xD;
      symptom of RP is constipation. Furthermore, the rectal prolapse can lead to anal pain as a&#xD;
      result of incarceration leading to ulcers, necrosis and perforation.&#xD;
&#xD;
      Besides the fact that this disease has a considerable impact on the individual quality of&#xD;
      life, it also carries significant socio-economic consequences as incontinence products have&#xD;
      to be used in large amounts.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    2 patients enrolled lost of follow-up after completing 1st year visits.PI decided to close&#xD;
  </why_stopped>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
    <description>Quality of Life objectified by the gastro-Intestinal Quality of Life Index and secondary by EuroQoL-5D and Short-Form 36 questionnaires.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Optimal surgery and functional results</measure>
    <time_frame>24 months</time_frame>
    <description>Compare 2 laparoscopic approaches and functional results evaluated by questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Rectal Prolapse</condition>
  <condition>Procidentia</condition>
  <arm_group>
    <arm_group_label>Cohort 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cohort 2 (two) will consist of 120 patients with an external rectal prolapse (Oxford Grade V)treated by Laparoscopic Resection Rectopexy (LRR). These patients will be included in the US centers involved in this study and treated by LRR.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cohort one will consist of 120 patients with an external rectal prolapse (Oxford Grade V) which will be treated with Laparoscopic Ventral Rectopexy. As this is the standard treatment in the European centers involved in this study these patients will be selected in the participating centers in the Netherlands, Belgium and England.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Resection Rectopexy</intervention_name>
    <description>laparoscopic sigmoidectomy with suture rectopexy</description>
    <arm_group_label>Cohort 2</arm_group_label>
    <other_name>Laparoscopic Resection Rectopexy,</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Ventral Rectopexy</intervention_name>
    <description>laparoscopic ventral rectopexy with mesh</description>
    <arm_group_label>Cohort 1</arm_group_label>
    <other_name>Laparoscopic ventral mesh rectopexy</other_name>
    <other_name>Ventral mesh rectopexy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with an indication for Laparoscopic Resection Rectopexy* for External&#xD;
             Rectal Prolapse (Oxford Grade V)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years of age&#xD;
&#xD;
          -  Former rectosigmoid resection&#xD;
&#xD;
          -  Former rectal prolapse surgery&#xD;
&#xD;
          -  Rectosigmoid tumor&#xD;
&#xD;
          -  Severe mental retardation&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven D Wexner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Floria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Floria</name>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <zip>33331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oschner Clinic North Shore</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70448</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01860</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2743</url>
    <description>Dutch Trial Register</description>
  </link>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>May 8, 2012</study_first_submitted>
  <study_first_submitted_qc>May 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2012</study_first_posted>
  <last_update_submitted>October 20, 2017</last_update_submitted>
  <last_update_submitted_qc>October 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Colorectal Surgery</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Rectal Prolapse</keyword>
  <keyword>Anorectal Physiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Prolapse</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

